REFERENCES
- Dannon P. N., Lowengrub K., Gonopolski Y., Musin E., Kotler M. Clinical Neuropharmacology 2005; 28: 6–10, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&db=pubmed&cmd=Retrieve&dopt=abstractplus&list_uids=15711432, [INFOTRIEVE], [CSA]
- Grant J. E., Kim S. W. Demographic and clinical features of 131 adult pathological gamblers. Journal of Clinical Psychiatry 2001; 62(12)957–962, [INFOTRIEVE], [CSA]
- Grant J. E., Kim S. W., Potenza M. N. Advances in the pharmacological treatment of pathological gambling. Journal of Gambling Studies 2003; 19, [CSA]
- Sood E. D., Pallanti S., Hollander E. Topiramate versus fluvoxamine in the treatment of pathological gambling: A randomized, blind-rater comparison study. Current Psychiatry Reports 2003; 5(1)9–15, [INFOTRIEVE], [CSA]